"Nanoantibiotics": A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era

Journal of Controlled Release

Volumn 156, Issue 2, 2011, Pages 128-145

  Huh, Ae Jung ^a,b   Kwon, Young Jik ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b National Health Insurance Corporation   (South Korea)

^c University of California at Irvine   (United States)

Author keywords

Antibiotics resistance; Antimicrobial drug delivery; Infectious disease; Nanoantibiotics; Nanoparticles

Indexed keywords

ADVERSE SIDE EFFECTS; ANIMAL MODEL; ANTI-MICROBIAL AGENT; ANTIBIOTIC AGENTS; ANTIBIOTICS RESISTANCE; ANTIMICROBIAL DRUG; DELIVERY SYSTEMS; DRUG RESISTANCE; HIGH DOSE; IN-VITRO; INFECTIOUS DISEASE; INNOVATIVE TECHNOLOGY; MULTIPLE DRUG RESISTANCE; NANO-SIZED; NANOANTIBIOTICS; PATHOGENIC MICROORGANISMS; UNDERLYING MECHANISM;

ANTIBIOTICS; DESIGN; DRUG DELIVERY; DRUG DOSAGE; DRUG INTERACTIONS; INNOVATION; MICROORGANISMS; NANOPARTICLES;

DISEASES;

ALUMINUM; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CARBON NANOTUBE; CEFALOTIN; CEFOTAXIME; CHITOSAN; CIPROFLOXACIN; COPPER; FULLERENE DERIVATIVE; GENTAMICIN; GOLD NANOPARTICLE; IMIPENEM; LINEZOLID; LIPOSOME; METICILLIN; NANOPARTICLE; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; POLYMYXIN B; SILVER NANOPARTICLE; SOLID LIPID NANOPARTICLE; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; TITANIUM DIOXIDE; TOBRAMYCIN; VANCOMYCIN; ZINC OXIDE;

ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; DRUG DELIVERY SYSTEM; HUMAN; INFECTION; MULTIDRUG RESISTANCE; NANOEMULSION; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, BACTERIAL; HUMANS; NANOMEDICINE; NANOSTRUCTURES; NANOTECHNOLOGY;

EID: 81255136231     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.07.002     Document Type: Review

References (281)

1. M.L. Cohen Changing patterns of infectious disease Nature 406 2000 762 767
2. H.S. Gold, and R.C. Moellering Antimicrobial-drug resistance N. Engl. J. Med. 335 1996 1445 1453
3. C. Walsh Molecular mechanisms that confer antibacterial drug resistance Nature 406 2000 775 781
4. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards Jr., D. Gilbert, L.B. Rice, M. Scheld, B. Spellberg, and J. Bartlett Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin. Infect. Dis. 48 2009 1 12
5. L.B. Rice The clinical consequences of antimicrobial resistance Curr. Opin. Microbiol. 12 2009 476 481
6. P.W. Talyor, P.D. Stapleton, and J.P. Luzio New ways to treat bacterial infections Drug Discov. Today 7 21 2002 1086 1091 (Pubitemid 35341649)
7. M. Rai, A. Yadav, and A. Gade Silver nanoparticles as a new generation of antimicrobials Biotechnol. Adv. 27 2009 76 83
8. C.M. Goodman, C.D. McCusker, T. Yilmaz, and V.M. Rotello Toxicity of gold nanoparticles functionalized with cationic and anionic side chains Bioconjug. Chem. 15 2004 897 900 (Pubitemid 38981966)
9. M. Schaller, J. Laude, H. Bodewaldt, G. Hamm, and H.C. Korting Toxicity and antimicrobial activity of a hydrocolloid dressing containing silver particles in an ex vivo model of cutaneous infection Skin Pharmacol. Physiol. 17 2004 31 36 (Pubitemid 38250477)
10. S. Pal, Y.K. Tak, and J.M. Song Dose the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli Appl. Environ. Microbiol. 27 6 2007 1712 1720 (Pubitemid 46449051)
11. E. Weir, A. Lawlor, A. Whelan, and F. Regan The use of nanoparticles in anti-microbial materials and their characterization Analyst 133 2008 835 845
12. R.P. Allaker, and G. Ren Potential impact of nanotechnology on the control of infectious disease Trans. R. Soc. Trop. Med. Hyg. 102 1 2008 1 2 (Pubitemid 350177423)
13. G. Taubes The bacteria fight back Science 321 2008 356 361
14. R.E. Siegel Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences Respir. Care 53 4 2008 471 479
15. S.P. Chakraborty, S.K. Sahu, S.K. Mahapatra, S. Susmita, M. Bal, S. Roy, and P. Pramanik Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents Nanotechnology 21 2010 1 9
16. B. Périchon, and P. Courvalin VanA-type vancomycin-resistant Staphylococcus aureus Antimicrob. Agents Chemother. 53 11 2009 4580 4587
17. H.M. Lode Clinical impact of antibiotic-resistant gram-positive pathogens Clin. Microbiol. Infect. 15 3 2009 212 217
18. F.E. Berkowitz Antibiotic resistance in bacteria South. Med. J. 88 8 1995 797 804
19. Eurosurveillance editorial team, information resources and latest news about the Shiga toxin-producing Escherichia coli (STEC) outbreak in Germany available from ECDC Euro Surveill. 16 23 2011 19886
20. A. Tuffs Bean sprouts are identified as cause of E. coli outbreak BMJ 14 2011 342
21. R. Hyde Germany reels in the wake of E. coli outbreak Lancet 377 2011 9782
22. E. Turos, G.S. Reddy, K. Greenhalgh, P. Ramaraju, S.C. Abeylath, S. Jang, S. Dickey, and D.V. Lim Penicillin-bound polyacrylate nanoparticles: restoring the activity of β-lactam antibiotics against MRSA Bioorg. Med. Chem. Lett. 17 2007 3468 3472 (Pubitemid 46830890)
23. S. Hemaiswarya, A.K. Kruthiventi, and M. Doble Synergism between natural products and antibiotics against infectious diseases Phytomedicine 15 2008 639 652
24. J.W. Kim, E.V. Shashkov, E.I. Galanzha, N. Ktagiri, and V.P. Zharov Photothermal antimicrobial nanotherapy and nanodiagnostics with self-assembling carbon nanotube clusters Lasers Surg. Med. 39 2007 622 634 (Pubitemid 47505214)
25. C. Beaulac, S. Clement-Major, J. Hawari, and J. Legace Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection Antimicrob. Agents Chemother. 40 1996 665 669
26. K.M. Hindi, A.J. Ditto, M.J. Panzner, D.A. Medvetz, D.S. Han, C.E. Hovis, J.K. Hilliard, J.B. Taylor, Y.H. Yun, C.L. Cannon, and W.J. Youngs The antimicrobial efficacy of sustained release silver-carbene complex-loaded l-tyrosine polyphosphate nanoparticles: Characterization, in vitro and in vivo studies Biomaterials 30 2009 3771 3779
27. C. Kaittanis, S. Santra, and J.M. Perez Emerging nanotechnology-based strategies for the identification of microbial pathogenesis Adv. Drug Deliv. Rev. 62 4-5 2010 408 423
28. K.K. Jain Applications of nanobiotechnology in clinical diagnostics Clin. Chem. 53 11 2007 2002 2007
29. N.L. Rosi, and C.A. Mirkin Nanostructures in biodiagnostics Chem. Rev. 105 2005 1547 1562 (Pubitemid 40596871)
30. M. Look, A. Bandyopadhyay, J.S. Blum, and T.M. Fahmy Application of nanotechnologies for improved immune response against infectious diseases in the developing world Adv. Drug Deliv. Rev. 62 4-5 2010 378 393
31. A. de la Escosura-Muñiz, and A. Merkoçi A nanochannel/nanoparticle-based filtering and sensing platform for direct detection of a cancer biomarker in blood Small 7 5 2011 675 682
32. M. Li, B. Hu, J. Li, R. Chen, X. Zhang, and H. Chen Extractive electrospray ionization mass spectrometry toward in situ analysis without sample pretreatment Anal. Chem. 81 18 2009 7724 7731
33. X. Zhao, L.R. Hilliard, S.J. Mechery, Y. Wang, R.P. Bagwe, S. Jin, and W. Tan A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles Rroc. Natl. Acad. Sci. U. S. A. 101 42 2004 15027 15032 (Pubitemid 39391712)
34. M. Basu, S. Seggerson, J. Henshaw, J. Jiang, R. Cordna, C. Lefave, P.J. Boyle, A. Miller, M. Pugia, and S. Basu Nano-biosensor development for bacterial detection during human kidney infection: use of glycoconjugate-specific antibody-bound gold nanowire arrays (GNWA) Glycoconj. J. 21 2004 487 496 (Pubitemid 40585509)
35. Y.C. Cao, R. Jin, and C.A. Mirkin Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection Science 297 2002 1536 1540 (Pubitemid 34970997)
36. C. Kaittanis, S. Nath, and J.M. Perez Rapid nanoparticle-mediated monitoring of bacterial metabolic activity and assessment of antimicrobial susceptibility in blood with magnetic relaxation PLoS One 3 9 2008 e3253
37. C. Kaittanis, S.A. Naser, and J.M. Perez One-step, nanoparticle-mediated bacterial detection with magnetic relaxation Nano Lett. 7 2 2007 380 383 (Pubitemid 46383601)
38. H.L. Grossman, W.R. Myers, V.J. Vreeland, R. Bruehl, M.D. Alper, C.R. Bertozzi, and J. Clarke Detection of bacteria in suspension by using a superconducting quantum interference device Proc. Natl. Acad. Sci. 101 1 2004 129 134 (Pubitemid 38084215)
39. E. Tully, S. Hearty, P. Leonard, and R. O'Kennedy The development of rapid fluorescence-based immunoassays, using quantum dot-labelled antibodies for the detection of Listeria monocytogenes cell surface proteins Int. J. Biol. Macromol. 39 1-3 2006 127 134 (Pubitemid 44066544)
40. M. Mühling, A. Bradford, J.W. Readman, P.J. Somerfield, and R.D. Handy An investigation into the effects of silver nanoparticles on antibiotic resistance of naturally occurring bacteria in an estuarine sediment Mar. Environ. Res. 68 2009 278 283
41. Z. Huang, X. Zheng, D. Yan, G. Yin, X. Liao, Y. Kang, Y. Yao, D. Huang, and B. Hao Toxicological effect of ZnO nanoparticles based on bacteria Langmuir 24 8 2008 4140 4144 (Pubitemid 351569021)
42. 2 reaction: toward an understanding of its killing mechanism Appl. Environ. Microbiol. 65 9 1999 4094 4098
43. Q. Li, S. Mahendra, D.Y. Lyon, L. Brunet, M.V. Liga, D. Li, and P.J. Alvarez Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications Water Res. 42 2008 4591 4602
44. E. Turos, J.Y. Shim, Y. Wang, K. Greenhalgh, G. Suresh Kumar Reddy, S. Dickey, and D.V. Lim Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents Bioorg. Med. Chem. Lett. 17 1 2007 53 56 (Pubitemid 46001585)
45. H. Gu, P.L. Ho, E. Tong, L. Wang, and B. Xu Presenting vancomycin on nanoparticles to enhance antimicrobial activities Nano Lett. 3 2003 1261 1263 (Pubitemid 37206074)
46. V.P. Zharov, K.E. Mercer, E.N. Galitovskaya, and M.S. Smeltzer Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacterial targeted with gold nanoparticles Biophys. J. 90 2 2006 619 627
47. V.P. Zharov, E.I. Galanzha, E.V. Shashkov, J.W. Kim, N.G. Khlebtsov, and V.V. Tuchin Photoacoustic flow cytometry: principle and application for real-time detection of circulating single nanoparticles, pathogens, and contrast dyes in vivo J. Biomed. Opt. 12 5 2007 051503
48. S.C. Abeylath, and E. Turos Drug delivery approaches to overcome bacterial resistance to β-lactam antibiotics Expert Opin. Drug Deliv. 5 9 2008 931 949
49. L.J. Peek, C.R. Middaugh, and C. Berkland Nanotechnology in vaccine delivery Adv. Drug Deliv. Rev. 60 8 2008 915 928
50. M. Singh, A. Chakrapani, and D. O'Hagan Nanoparticles and microparticles as vaccine-delivery systems Expert Rev. Vaccines 6 5 2007 797 808 (Pubitemid 47607854)
51. A.C. Rice-Ficht, A.M. Arenas-Gamboa, M.M. Kahl-McDonagh, and T.A. Ficht Polymeric particles in vaccine delivery Curr. Opin. Microbiol. 13 1 2010 106 112
52. P. Johansen, C. Raynaud, M. Yang, M.J. Colston, R.E. Tascon, and D.B. Lowrie Anti-mycobacterial immunity induced by a single injection of M. leprae Hsp65-encoding plasmid DNA in biodegradable microparticles Immunol. Lett. 90 2-3 2003 81 85 (Pubitemid 37548462)
53. A. Myc, J.F. Kukowska-Latallo, A.U. Bielinska, P. Cao, P.P. Myc, K. Janczak, T.R. Sturm, M.S. Grabinski, J.J. Landers, K.S. Young, J. Chang, T. Hamouda, M.A. Olszewski, and J.R. Baker Jr. Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion Vaccine 21 25-26 2003 3801 3814 (Pubitemid 37338208)
54. A.U. Bielinska, K.W. Janczak, J.J. Landers, P. Makidon, L.E. Sower, J.W. Peterson, and J.R. Baker Jr. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective vaccine protects against Bacillus anthracis spore challenge Infect. Immun. 75 8 2007 4020 4029 (Pubitemid 47206301)
55. J.S. Kim, E. Kuk, K.N. Yu, J.H. Kim, S.J. Park, H.J. Lee, S.H. Kim, Y.K. Park, Y.H. Park, C.Y. Hwang, Y.K. Kim, Y.S. Lee, D.H. Jeong, and M.H. Cho Antimicrobial effects of silver nanoparticles Nanomedicine 3 2007 95 101 (Pubitemid 46428190)
56. H.M. Mansour, Y.S. Rhee, and X. Wu Nanomedicine in pulmonary delivery Int. J. Nanomedicine 4 2009 299 319
57. N.S. Santos-Magalhães, and V.C. Mosqueira Nanotechnology applied to the treatment of malaria Adv. Drug Deliv. Rev. 62 2010 560 575
58. A. Sosnik, A.M. Carcaboso, R.J. Glisoni, M.A. Moretton, and D.A. Chiappetta New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery Adv. Drug Deliv. Rev. 62 2010 547 559
59. E.I. Rabea, M.E. Badawy, C.V. Stevens, G. Smagghe, and W. Steurbaut Chitosan as antimicrobial agent: applications and mode of action Biomacromolecules 4 6 2003 1457 1465 (Pubitemid 37455555)
60. A. Nanda, and M. Saravanan Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE Nanomedicine 5 4 2009 452 456
61. D.S. Balaji, S. Basavaraja, R. Deshpande, D.B. Mahesh, B.K. Prabhakar, and A. Venkataraman Extracellular biosynthesis of functionalized silver nanoparticles by strains of Cladosporium cladosporioides fungus Colloids Surf. B Biointerfaces 68 2009 88 92
62. S. Basavaraja, S.D. Balaji, A. Lafashetty, A.H. Rajasab, and A. Venkataraman Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium semitectum Mater. Res. Bull. 43 2008 1164 1170 (Pubitemid 351381539)
63. J.D. Holmes, P.R. Smith, R. Evans-Gowing, D.J. Richardson, D.A. Russell, and J.R. Sodeau Energy-dispersive X-ray analysis of the extracellular cadmium sulfide crystallites of Klebsiella aerogenes Arch. Microbiol. 163 2 1995 143 147
64. M. Saravanan, and A. Nanda Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSE Colloids Surf. B Biointerfaces 77 2010 214 218
65. + in Vibrio cholera Antimicrob. Agents Chemother. 46 8 2002 2668 2670 (Pubitemid 34793484)
66. I. Chora The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J. Antimicrob. Chemother. 59 2007 587 590
67. Y. Liu, L. He, A. Mustapha, H. Li, Z.Q. Hu, and M. Lin Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7 J. Appl. Microbiol. 107 2009 1193 1201
68. M. Chamundeeswari, S.S. Sobhana, J.P. Jacob, M.G. Kumar, M.P. Devi, T.P. Sastry, and A.B. Mandal Preparation, characterization and evaluation of a biopolymeric gold nanocomposite with antimicrobial activity Biotechnol. Appl. Biochem. 55 2010 29 35
69. 4@Au nanoeggs as photothermal agents for selective killing of nosocomial and antibiotic-resistant bacteria Small 5 1 2009 51 56
70. V.K. Sharma, R.A. Yngard, and Y. Liu Silver nanoparticles: green synthesis and their antimicrobial activities Adv. Colloid Interface Sci. 145 1-2 2008 83 96
71. H.J. Klasen Historical review of the use of silver in the treatment of burns. I. Early uses Burns 26 2000 117 130 (Pubitemid 30050604)
72. F. Raimondi, G.G. Scherer, R. Kötz, and A. Wokaun Nanoparticles in energy technology: examples from electrochemistry and catalysis Angew. Chem. Int. Ed Engl. 44 2005 2190 2209 (Pubitemid 40572849)
73. I. Sondi, and B. Salopek-Sondi Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram-negative bacteria J. Colloid Interface Sci. 275 2004 177 182 (Pubitemid 38670216)
74. A.R. Shahverdi, A. Fakhimi, H.R. Shahverdi, and S. Minaian Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli Nanomedicine 3 2 2007 168 171 (Pubitemid 46899614)
75. A.M. Fayaz, K. Balaji, M. Girilal, R. Yadav, M. Tech, P.T. Kalaichelvan, and R. Venketesan Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria Nanomedicine 6 2010 103 109
76. F. Furno, K.S. Morley, B. Wong, B.L. Sharp, P.L. Arnold, S.M. Howdle, R. Bayston, P.D. Brown, P.D. Winship, and H.J. Reid Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J. Antimicrob. Chemother. 54 2004 1019 1024 (Pubitemid 40136734)
77. M. Ip, S.L. Lui, V.K. Poon, I. Lung, and A. Burd Antimicrobial activities of silver dressings: an in vitro comparison J. Med. Microbiol. 55 2006 59 63 (Pubitemid 43031239)
78. D.J. Leaper Silver dressings: their role in wound management Int. Wound J. 3 4 2006 282 294
79. Y. Li, P. Leung, L. Yao, Q.W. Song, and E. Newton Antimicrobial effect of surgical masks coated with nanoparticles J. Hosp. Infect. 62 2006 58 63 (Pubitemid 43103011)
80. P.L. Drake, and K.J. Hazelwood Exposure-related health effects of silver and silver compounds: a review Ann. Occup. Hyg. 49 7 2005 575 585 (Pubitemid 41442683)
81. H.J. Johnston, G. Hutchison, F.M. Christensen, S. Peters, S. Hankin, and V. Stone A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity Crit. Rev. Toxicol. 40 4 2010 328 346
82. G. Oberdörster, E. Oberdörster, and J. Oberdörster Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environ. Health Perspect. 113 7 2005 823 939
83. L. Braydich-Stolle, S. Hussainn, J.J. Schlager, and M.C. Hofmann In vitro cytotoxicity of nanoparticles in mammalian germline stem cells Toxicol. Sci. 88 2005 412 419 (Pubitemid 41672149)
84. S.M. Hussain, K.L. Hess, J.M. Gearhart, K.T. Geiss, and J.J. Schlager In vitro toxicity of nanoparticles in BRL 3A rat liver cells Toxicol. In Vitro 19 2005 975 983 (Pubitemid 41563236)
85. R. Brayner, R. Ferarri-Iliou, N. Brivois, S. Djediat, M.F. Benedetti, and F. Fiévet Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium Nano Lett. 6 2006 866 870
86. K.M. Reddy, K. Feris, J. Bell, D.G. Wingett, C. Hanley, and A. Punnoose Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems Appl. Phys. Lett. 90 2007 2139021 2139023 (213902)
87. 2 nanocomposites for antimicrobial coatings J. Phys. Chem. B 109 2005 8889 8898 (Pubitemid 40750925)
88. P. Jiang, J.J. Zhou, H.F. Fang, C.Y. Wang, Z.L. Wang, and S.S. Xie Hierarchical shelled ZnO structures made of bunched nanowire arrays Adv. Funct. Mater. 17 2007 1303 1310 (Pubitemid 46847645)
89. J. Zhou, N. Xu, and Z.L. Wang Dissolving behavior and stability of ZnO wires in biofluids: a study on biodegradability and biocompatibility of ZnO nanostructures Adv. Mater. 18 2006 2432 2435 (Pubitemid 44495410)
90. M. Roselli, A. Finamore, I. Garaguso, M.S. Britti, and E. Mengheri Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli J. Nutr. 133 12 2003 4077 4082 (Pubitemid 37505479)
91. R. Dastjerdi, and M. Montazer A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties Colloids Surf. B Biointerfaces 79 1 2010 5 18
92. S.S. Uǧur, M. SarIIşIk, A.H. Aktaş, M.C. Uçar, and E. Erden Modifying of cotton fabric surface with nano-ZnO multilayer films by layer-by-layer deposition method Nanoscale Res. Lett. 5 2010 1204 1210
93. J. Sawai Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay J. Microbiol. Methods 54 2 2003 177 182 (Pubitemid 36629531)
94. 2 films and sunlight Water Res. 40 2006 3274 3280 (Pubitemid 44349004)
95. 2 as Escherichia coli disinfection photocatalyst Water Res. 41 2007 379 386 (Pubitemid 44937743)
96. K.P. Kühn, I.F. Cahberny, K. Massholder, M. Stickler, V.W. Benz, H. Sonntag, and L. Erdinger Disinfection of surfaces by photocatalytic oxidation with titanium dioxide and UVA light Chemosphere 53 2003 71 77 (Pubitemid 38340443)
97. O.J. Oppezzo, and R.A. Pizarro Sublethal effects of ultraviolet A radiation on Enterobacter cloacae J. Photochem. Photobiol. B 62 2001 158 165 (Pubitemid 32898837)
98. 2 film formed on Ti and TiAg exposed to Lactobacillus acidophilus J. Biomed. Mater. Res. B Appl. Biomater. 80 2 2007 353 359
99. 2, and ZnO water suspensions Water Res. 40 19 2006 3527 3532 (Pubitemid 44527981)
100. P. Muranyi, C. Schraml, and J. Wunderlich Antimicrobial efficiency of titanium dioxide-coated surfaces J. Appl. Microbiol. 108 6 2010 1966 1973
101. 2) codoped with silver, carbon, and sulfur Langmuir 26 4 2010 2805 2810
102. B.S. Sekhon, and S.R. Kamboj Inorganic nanomedicine-part 2 Nanomedicine 6 5 2010 612 618
103. D. Pissuwan, C.H. Cortie, S.M. Valenzuela, and M.B. Cortie Functionalised gold nanoparticles for controlling pathogenic bacteria Trends Biotechnol. 28 4 2010 207 213
104. A.N. Grace, and K. Pandian Antibacterial efficacy of aminoglycosidic antibiotics protected gold nanoparticles-a brief study Colloids Surf., A 297 2007 63 70 (Pubitemid 46274217)
105. I.M. Sadiq, B. Chowdhury, N. Chandrasekaran, and A. Mukherjee Antimicrobial sensitivity of Escherichia coli to alumina nanoparticles Nanomedicine 5 2009 282 286
106. J.J. Buckley, P.L. Gai, A.F. Lee, L. Olivi, and K. Wilson Silver carbonate nanoparticles stabilized over alumina nanoneedles exhibiting potent antibacterial properties Chem. Commun. (Camb.) 14 34 2008 4013 4015
107. L. Esteban-Tejeda, F. Malpartida, A. Esteban-Cubillo, C. Pecharromán, and J.S. Moya Antibacterial and antifungal activity of a soda-lime glass containing copper nanoparticles Nanotechnology 20 50 2009 505701
108. H.L. Pape, F.S. Serena, P. Contini, C. Devillers, A. Maftah, and P. Leprat Evaluation of the anti-microbial properties of an activated carbon fibre supporting silver using a dynamic method Carbon 40 2002 2947 2954 (Pubitemid 35276329)
109. J.P. Ruparelia, A.K. Chatterijee, S.P. Duttagupta, and S. Mukherji Strain specificity in antimicrobial activity of silver and copper nanoparticles Acta Biomater. 4 2008 707 716 (Pubitemid 351461288)
110. K.Y. Yoon, J. Hoon Byeon, J.H. Park, and J. Hwang Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles Sci. Total Environ. 373 2-3 2007 572 575 (Pubitemid 46177188)
111. G. Ren, D. Hu, E.W. Cheng, M.A. Vargas-Reus, P. Reip, and R.P. Allaker Characterisation of copper oxide nanoparticles for antimicrobial applications Int. J. Antimicrob. Agents 33 6 2009 587 590
112. Y.C. Chung, H.L. Wang, Y.M. Chen, and S.L. Li Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens Bioresour. Technol. 88 2003 179 184
113. L. Qi, Z. Xu, X. Jiang, C. Hu, and X. Zou Preparation and antibacterial activity of chitosan nanoparticles Carbohydr. Res. 339 2004 2693 2700 (Pubitemid 39425140)
114. T.M. Don, C.C. Chen, C.K. Lee, W.Y. Cheng, and L.P. Cheung Preparation and antibacterial test of chitosan/PAA/PEGDA bi-layer composite membranes J. Biomater. Sci. Polym. Ed. 16 12 2005 1503 1519
115. H.K. No, N.Y. Park, S.H. Lee, and S.P. Meyers Antibacterial activity of chitosans and chitosan oligomers with different molecular weights Int. J. Food Microbiol. 74 1 2002 65 72 (Pubitemid 34203704)
116. J.C. Fernandes, F.K. Tavaria, J.C. Soares, O.S. Ramos, M. João Monteiro, M.E. Pintado, and F. Xavier Malcata Antimicrobial effects of chitosans and chitooligosacharides, upon Staphylococcus aureus and Escherichia coli, in food model systems Food Microbiol. 25 2008 922 928
117. J.C. Fernandes, F.K. Tavaria, S.C. Fonseca, O.S. Ramos, M.E. Pintado, and F.X. Malcata In vitro screening for anti-microbial activity of chitosans and chitooligosaccharides, aiming at potential uses in functional textiles J. Microbiol. Biotechnol. 20 2 2010 311 318
118. S. Tin, K.R. Sakharkar, C.S. Lim, and M.K. Sakharkar Activity of chitosans in combination with antibiotics in Pseudomonas aeruginosa Int. J. Biol. Sci. 5 2 2009 153 160
119. R.G. Cureo, G. Osuji, and A. Washington N-carboxymethylchitosan inhibition of aflatoxin production: role or zinc Biotechnol. Lett. 13 1991 441 444
120. J.Y. Je, and S.K. Kim Chitosan derivatives killed bacteria by disrupting the outer and inner membrane J. Agric. Food Chem. 54 18 2006 6629 6633
121. K. Xing, X.G. Chen, C.S. Liu, D.S. Cha, and H.J. Park Oleoyl-chitosan nanoparticles inhibits Escherichia coli and Staphylococcus aureus by damaging the cell membrane and putative binding to extracellular or intracellular targets Int. J. Food Microbiol. 132 2009 127 133
122. N. Tsao, T.Y. Luh, C.K. Chou, T.Y. Chang, J.J. Wu, C.C. Liu, and H.Y. Lei In vitro action of carboxyfullerene J. Antimicrob. Chemother. 49 2002 641 649 (Pubitemid 34428979)
123. J.A. Brant, J. Labille, J.Y. Bottero, and M.R. Wiesner Characterizing the impact of preparation method on fullerene cluster structure and chemistry Langmuir 22 2006 3878 3885 (Pubitemid 43672564)
124. D.Y. Lyon, J.D. Fortner, C.M. Sayes, V.L. Colvin, and J.B. Hughe Bacterial cell association and antimicrobial activity of a C60 water suspension Environ. Toxicol. Chem. 24 11 2005 2757 2762 (Pubitemid 41500771)
125. 60 cytotoxicity is due to lipid peroxidation Biomaterials 26 2005 7587 7595 (Pubitemid 41187558)
126. Z. Markovic, B. Todorovic-Markovic, D. Kleut, N. Nikolic, S. Vranjes-Djuric, M. Misirkic, L. Vucicevic, K. Janjetovic, A. Isakovic, L. Harhaji, B. Babic-Stojic, M. Dramicanin, and V. Trajkovic The mechanism of cell-damaging reactive oxygen generation by colloidal fullerenes Biomaterials 28 2007 5437 5448 (Pubitemid 47603199)
127. D.Y. Lyon, L. Brunet, G.W. Hinkal, M.R. Wiesner, and P.J. Alvarez Antibacterial activity of fullerene water suspensions (nC60) is not due to ROS-medicated damage Nano Lett. 8 5 2008 1539 1543
128. J. Fang, D.Y. Lyon, M.R. Weisner, and P.J. Alvarez Effect of a fullerene water suspension on bacterial phospholipids and membrane phase behavior Environ. Sci. Technol. 41 7 2007 2636 2642 (Pubitemid 46595239)
129. X.R. Xia, N.A. Monteiro-Riviere, and J.E. Riviere Intrinsic biological property of colloidal fullerene nanoparticles (nC60): lack of lethality after high dose exposure to human epidermal and bacterial cells Toxicol. Lett. 197 2 2010 128 134
130. A. Isakovic, Z. Markovic, N. Nikolic, B. Todorovic-Markovic, S. Vranjes-Djuric, L. Harhaji, N. Raicevic, N. Romcevic, D. Vasiljevic-Radovic, M. Dramicanin, and V. Trajkovic Inactivation of nanocrystalline C60 cytotoxicity by gamma-irradiation Biomaterials 27 29 2006 5049 5058 (Pubitemid 43928129)
131. G.L. Baker, A. Gupta, M.L. Clark, B.R. Valenzuela, L.M. Staska, S.J. Harbo, J.T. Pierce, and J.A. Dill Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles Toxicol. Sci. 101 1 2008 122 131 (Pubitemid 350239016)
132. N. Gharbi, M. Pressac, M. Hadchouel, H. Szwarc, S.R. Wilson, and F. Moussa [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity Nano Lett. 5 12 2005 2578 2585 (Pubitemid 43088916)
133. T. Mashino, D. Nishikawa, K. Takahashi, N. Usui, T. Yamori, M. Seki, T. Endo, and M. Mochizuki Antibacterial and antiproliferative activity of cationic fullerene derivatives Bioorg. Med. Chem. Lett. 13 24 2003 4395 4397 (Pubitemid 37490825)
134. H. Aoshima, K. Kokubo, S. Shirakawa, M. Ito, S. Yamana, and T. Oshima Antimicrobial activity of fullerenes and their hydroxylated derivatives Biocontrol Sci. 14 2 2009 69 72
135. x in mice J. Nanopart. Res. 8 2006 53 63 (Pubitemid 43760675)
136. A. Isakovic, Z. Markovic, B. Todorovic-Markovic, N. Nikolic, S. Vranjes-Djuric, M. Mirkovic, M. Dramicanin, L. Harhaji, N. Raicevic, Z. Nikolic, and V. Trajkovic Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene Toxicol. Sci. 91 1 2006 173 183
137. J.E. Roberts, A.R. Wielgus, W.K. Boyes, U. Andley, and C.F. Chignell Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells Toxicol. Appl. Pharmacol. 228 1 2007 49 58
138. A.R. Wielgus, B. Zhao, C.F. Chignell, D.N. Hu, and J.E. Roberts Phototoxicity and cytotoxicity of fullerol in human retinal pigment epithelial cells Toxicol. Appl. Pharmacol. 242 1 2010 79 90
139. D. Lyon, L. Adams, and J. Falkner Antibacterial activity of fullerene water suspensions: effect of preparation method and particle size Environ. Sci. Technol. 40 2006 4360 4366 (Pubitemid 44109659)
140. H. Hyung, J.D. Fortner, J.B. Hughes, and J.H. Kim Natural organic matter stabilizes carbon nanotubes in the aqueous phase Environ. Sci. Technol. 41 1 2007 179 184 (Pubitemid 46047840)
141. L.R. Arias, and L. Yang Inactivation of bacterial pathogens by carbon nanotubes in suspensions Langmuir 25 2009 3003 3012
142. P. Wick, P. Manser, L.K. Limbach, U. Dettlaff-Weglikowska, R. Krumeich, S. Roth, W.J. Stark, and A. Bruinink The degree and kind of agglomeration affect carbon nanotube cytotoxicity Toxicol. Lett. 168 2007 121 131 (Pubitemid 46054362)
143. G. Jia, H. Wang, L. Yan, X. Wang, R. Pei, T. Yan, T. Zhao, and X. Guo Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene Environ. Sci. Technol. 39 5 2005 1378 1383 (Pubitemid 40333400)
144. D.B. Warheit, B.R. Laurence, K.L. Reed, D.H. Roach, G.A. Reynolds, and T.R. Webb Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats Toxicol. Sci. 77 1 2004 117 125 (Pubitemid 38128651)
145. C.W. Lam, J.T. James, R. McCluskey, and R.L. Hunter Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation Toxicol. Sci. 77 1 2004 126 134 (Pubitemid 38128652)
146. S. Kang, M. Pinault, L.D. Pfefferle, and M. Elimelech Single-walled carbon nanotubes exhibit strong antimicrobial activity Langmuir 23 2007 8670 8673 (Pubitemid 47294266)
147. A.S. Brady-Estévez, T.H. Nguyen, L. Gutierrez, and M. Elimelech Impact of solution chemistry on viral removal by a single-walled carbon nanotube filter Water Res. 44 2010 3773 3780
148. S. Aslan, C.Z. Loebick, S. Kang, M. Elimelech, L.D. Pfefferle, and P.R. Van Tassel Antimicrobial biomaterials based on carbon nanotubes dispersed in poly(lactic-co-glycolic acid) Nanoscale 2 9 2010 1789 1794
149. C.D. Vecitis, K.R. Zodrow, S. Kang, and M. Elimelech Electronic- structure-dependent bacterial cytotoxicity of single-walled carbon nanotubes ACS Nano 4 9 2010 5471 5479
150. A.S. Brady-Estévez, S. Kang, and M. Elimelech A single-walled-carbon-nanotube filter for removal of viral and bacterial pathogens Small 4 4 2008 481 484 (Pubitemid 351641629)
151. A. Srivastava, O.N. Srivastava, S. Talapatra, R. Vajtai, and P.M. Ajayan Carbon nanotube filters Nat. Mater. 3 2004 610 614
152. T. Maisch A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment Mini Rev. Med. Chem. 9 8 2009 974 983
153. F.C. Fang Antimicrobial reactive oxygen and nitrogen species: concepts and controversies Nat. Rev. Microbiol. 2 2004 820 832 (Pubitemid 39317463)
154. R.B. Weller Nitric oxide-containing nanoparticles as an antimicrobial agents and enhancer of wound healing J. Invest. Dermatol. 129 2009 2335 2337
155. R. Weller, R.J. Price, A.D. Ormerod, N. Benjamin, and C. Leifert Antimicrobial effect of acidified nitrite on dermatophyte fungi, Candida and bacterial skin pathogens J. Appl. Microbiol. 90 2001 648 652 (Pubitemid 32291268)
156. L.R. Martinez, G. Han, M. Chacko, M.R. Mihu, M. Jacobson, P. Gialanella, A.J. Friedman, J.D. Nosanchuk, and J.M. Friedman Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection J. Invest. Dermatol. 129 2009 2463 2469
157. R. Weller, and M.J. Finnen The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice Nitric Oxide 15 2006 395 399 (Pubitemid 44754941)
158. M. Mowbray, X. Tan, P.S. Wheatley, R.E. Morris, and R.B. Weller Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation J. Invest. Dermatol. 128 2009 352 360
159. E.M. Hetrick, J.K. Shin, H.S. Paul, and M.H. Schoenfisch Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles Biomaterials 30 14 2009 2782 2789
160. E.M. Hetrick, J.H. Shin, N.A. Stasko, C.B. Johnson, D.A. Wespe, E. Holmuhamedov, and M.H. Schoenfisch Bactericidal efficacy of nitric oxide-releasing silica nanoparticles ACS Nano 2 2 2008 235 246 (Pubitemid 351585938)
161. R.P. Bagwe, L.R. Hilliard, and W. Tan Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding Langmuir 22 2006 4357 4362
162. N. Barraud, D.J. Hassett, S.H. Hwang, S.A. Rice, S. Kjelleberg, and J.S. Webb Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa J. Bacteriol. 188 2006 7344 7353 (Pubitemid 44646233)
163. G. Han, L.R. Martinez, M.R. Mihu, A.J. Friedman, and J.M. Friedman Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection PLoS One 4 11 2009 1 7 e7804
164. J.J. LiPuma, S. Rathinavelu, B.K. Foster, J.C. Keoleian, P.E. Makidon, L.M. Kalikin, and J.R. Baker Jr. In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species Antimicrob. Agents Chemother. 53 1 2009 249 255
165. M.J. Lawrencea, and G.D. Reesb Microemulsion-based media as novel drug delivery systems Adv. Drug Deliv. Rev. 45 2000 89 121
166. Y. Cao, and J. Sheng Microstructure of microemulsion in MEEKC Electrophoresis 31 4 2010 672 678
167. T. Hamouda, and J.R. Baker Jr. Antimicrobial mechanism of action of surfactant lipid preparations in enteric gram-negative bacilli J. Appl. Microbiol. 89 2000 397 403
168. T. Hamouda, M.M. Hayes, Z. Cao, R. Tonda, K. Johnson, D.C. Wright, J. Brisker, and J.R. Baker Jr. A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species J. Infect. Dis. 180 1999 1939 1949
169. I.S. Al-Adham, E. Khalil, N.D. Al-Hmoud, M. Kierans, and P.J. Collier Microemulsions are membrane-active, antimicrobial, self-preserving systems J. Appl. Microbiol. 89 2000 32 39 (Pubitemid 30602421)
170. I.S. Al-Adham, N.D. Al-Hmoud, E. Khalil, M. Kierans, and P.J. Collier Microemulsions are highly effective anti-biofilm agents Lett. Appl. Microbiol. 36 2003 97 100 (Pubitemid 36121015)
171. P.E. Makidon, A.U. Bielinska, S.S. Nigaverkar, K.W. Janczak, J. Knowlton, A.J. Scott, N. Mank, Z. Cao, S. Rathinavelu, M.R. Beer, J.E. Wilkinson, L.P. Blanco, J.J. Landers, and J.R. Baker Jr. Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine PLoS One 3 8 2008 e2954
172. A.U. Bielinska, K.W. Janczak, J.J. Landers, P. Makidon, L.E. Sower, J.W. Peterson, and J.R. Baker Jr. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge Infect. Immun. 75 8 2007 4020 4029 (Pubitemid 47206301)
173. L. Zhang, D. Pornpattananangkul, C.M. Hu, and C.M. Huang Development of nanoparticles for antimicrobial drug delivery Curr. Med. Chem. 17 2010 585 594
174. H.P. Alphandary, A. Andremont, and P. Couvreur Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications Int. J. Antimicrob. Agents 13 2000 155 168
175. L. Zhang, F.X. Gu, J.M. Chan, A.Z. Wang, R.S. Langer, and O.C. Farokhzad Nanoparticles in medicine: therapeutic applications and developments Clin. Pharmacol. Ther. 83 5 2008 761 769 (Pubitemid 351556021)
176. T. Lian, and R.J. Ho Trends and developments in liposome drug delivery systems J. Pharm. Sci. 90 6 2001 667 680 (Pubitemid 32530443)
177. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2 2005 145 160 (Pubitemid 40282557)
178. D.D. Lasic Novel applications of liposomes Trends Biotechnol. 16 7 1998 307 321 (Pubitemid 28305254)
179. K. Maruyama, S.J. Kennel, and L. Huang Lipid composition is important for highly efficient target binding and retention of immunoliposomes Proc. Natl. Acad. Sci. U.S.A. 87 1990 5744 5748
180. I.A. Bakker-Woudenberg Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci Int. J. Antimicrob. Agents 19 2002 299 311 (Pubitemid 34308978)
181. M. Moonis, I. Ahmad, and B.K. Bachhawat Effect of elimination of phagocytic cells by liposomal dichloromethylene diphosphonate on aspergillosis virulence and toxicity of liposomal amphotericin B in mice Antimicrob. Chemother. 33 3 1994 571 583 (Pubitemid 24110873)
182. T.M. Allen, C. Hansen, and J. Rutledge Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues Biochem. Biophys. Acta 981 1 1989 27 35 (Pubitemid 19127766)
183. A. Omri, Z.E. Suntres, and P.N. Shek Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection Biochem. Pharmacol. 64 2002 1407 1413 (Pubitemid 35248257)
184. M. Alipour, M. Halwani, A. Omri, and Z.E. Suntres Antimicrobial effectiveness of liposomal polymyxin B against resistant gram-negative bacterial strains Int. J. Pharm. 355 2008 293 298
185. C. Mugabe, M. Halwani, A.O. Azghani, R.M. Lafrenie, and A. Omri Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa Antimicrob. Agents Chemother. 50 6 2006 2016 2022 (Pubitemid 43807520)
186. D. Yang, D. Pornpattananangkul, T. Nakatsuji, M. Chan, D. Carson, C.M. Huang, and L. Zhang The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes Biomaterials 30 2009 6035 6040
187. I. Schumacher, and R. Margalit Liposome-encapsulted ampicillin: physicochemical and antibacterial properties J. Pharm. Sci. 86 5 1997 635 641 (Pubitemid 27203415)
188. H.J. Kim, and M.N. Jones The delivery of benzyl penicillin to Staphylococcus aureus J. Liposome Res. 14 3-4 2004 123 139 (Pubitemid 40052466)
189. M. Magallanes, J. Dijkstra, and J. Fierer Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis Antimicrob. Agents Chemother. 37 11 1993 2293 2297 (Pubitemid 23324446)
190. P.R. Gangadhanun, D.A. Ashtekar, N. Gborf, J.A. Goldstein, R.J. Debs, and N.D. fizgfines Chemotherapentic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice J. Antimicrob. Chemother. 28 1991 425 435
191. R.M. Fielding, R.O. Lewis, and L.M. McDermott Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome®) Pharm. Res. 15 11 1998 1775 1781 (Pubitemid 28524591)
192. I.A. Bakker-Woudenberg, M.T. ten Kate, L.E. Stearne-Cullene, and M.C. Woodle Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue J. Infect. Dis. 171 4 1995 938 947
193. C.O. Onyeji, C.H. Nightingale, and M.N. Marangos Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin Infection 22 5 1994 338 342 (Pubitemid 24316420)
194. S.A. Wissing, and R.H. Müller Cosmetic applications for solid lipid nanoparticles (SLN) Int. J. Pharm. 254 2003 65 68 (Pubitemid 36259812)
195. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur. J. Pharm. Biopharm. 50 1 2000 161 177 (Pubitemid 30326695)
196. R. Pandey, and G.K. Khuller Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis Tuberculosis 85 2005 227 234 (Pubitemid 40805619)
197. A. Bargoni, R. Cavalli, G.P. Zara, A. Fundarò, O. Caputo, and M.R. Gasco Transmucosal transport of tobramyin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II-tissue distribution Pharmacol. Res. 43 5 2001 497 502 (Pubitemid 32578867)
198. M.A. Videira, M.F. Botelho, A.C. Santos, L.F. Gouveia, J.J. de Lima, and A.J. Almeida Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles J. Drug Target. 10 8 2002 607 613 (Pubitemid 36124361)
199. R. Cavalli, M.R. Gasco, P. Chetoni, S. Burgalassi, and M.F. Saettone Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin Int. J. Pharm. 238 2002 241 245 (Pubitemid 34457892)
200. E.B. Souto, and R.H. Müller Cosmetic features and applications of lipid nanoparticles (SLN, NLC) Int. J. Cosmet. Sci. 30 3 2008 157 165 (Pubitemid 351623837)
201. E.B. Souto, S.A. Wissing, C.M. Barbosa, and R.H. Müller Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Int. J. Pharm. 278 2004 71 77 (Pubitemid 38670438)
202. A.K. Gupta, and E.A. Cooper Update in antifungal therapy of dermatophytosis Mycopathologia 166 2008 353 367
203. V. Sanna, E. Gavini, M. Cossu, G. Rassu, and P. Giunchedi Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies J. Pharm. Pharmacol. 59 8 2007 1057 1064 (Pubitemid 47265352)
204. C.W. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S93 S98
205. D. Jain, and R. Banerjee Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery J. Biomed. Mater. Res. B Appl. Biomater. 86 1 2008 105 112 (Pubitemid 351874373)
206. S. Gelperina, K. Kisich, M.D. Iseman, and L. Heifets The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis Am. J. Respir. Crit. Care Med. 172 12 2005 1487 1490 (Pubitemid 43076534)
207. J. Murray, L. Brown, and R. Langer Controlled release of microquantities of macromolecules Cancer Drug Deliv. 1 2 1984 119 123 (Pubitemid 15187890)
208. R.A. Siegel, and R. Langer Controlled release of polypeptides and other macromolecules Pharm. Res. 1 1 1984 2 10 (Pubitemid 14123791)
209. R. Langer, and J. Folkman Polymers for the sustained release of proteins and other macromolecules Nature 263 1976 797 800
210. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J. Control. Release 70 2001 1 20 (Pubitemid 32144788)
211. R.B. Umamaheshwari, and N.K. Jain Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori J. Drug Target. 11 7 2003 415 424 (Pubitemid 38455827)
212. C. Vauthier, C. Dubernet, E. Fattal, H. Pinto-Alphandary, and P. Couvreur Poly (alkylcyanoacrylates) as biodegradable materials for biomedical applications Adv. Drug Deliv. Rev. 55 2003 519 548 (Pubitemid 36423302)
213. S.C. Abeylath, E. Turos, S. Dickey, and D.V. Limb Glyconanobiotics: novel carbohydrate nanoparticle antibiotics for MRSA and Bacillus anthracis Bioorg. Med. Chem. 16 5 2008 2412 2418 (Pubitemid 351403660)
214. D.E. Owens 111, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102 (Pubitemid 41773257)
215. S.R. Croy, and G.S. Kwon Polymeric micelles for drug delivery Curr. Pharm. Des. 12 2006 4669 4684 (Pubitemid 44835136)
216. J. Cheng, B.A. Teply, I. Sherifi, J. Sung, G. Luther, F.X. Gu, E. Levy-Nissenbaum, A.F. Radovic-Moreno, R. Langer, and O.C. Farokhzad Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery Biomaterials 28 2007 869 876 (Pubitemid 44667020)
217. F. Gu, L. Zhang, B.A. Teply, N. Mann, A. Wang, A.F. Radovic-Moreno, R. Langer, and O.C. Farokhzad Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers Proc. Natl. Acad. Sci. U.S.A. 105 7 2008 2586 2591 (Pubitemid 351520557)
218. E. Fettal, M. Youssef, P. Couvreur, and A. Andremont Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles Antimicrob. Agents Chemother. 33 9 1989 1540 1543 (Pubitemid 19228010)
219. F. Forestier, P. Gerrier, C. Chaumard, A.M. Quero, P. Couvreurr, and C. Labarre Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages J. Antimicrob. Chemother. 30 1992 173 179
220. 3H)ampicillin- loaded nanoparticles J. Antimicrob. Chemother. 37 1996 105 115 (Pubitemid 26123139)
221. G. Fontana, G. Pitarresi, V. Tomarchio, B. Carlisi, and P.L. San Biagio Preparation, characterization and in vitro antimicrobiral activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles Biomaterials 19 1998 1009 1017 (Pubitemid 28331617)
222. G. Fontana, M. Licciardi, S. Mansueto, D. Schillaci, and G. Giammona Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake Biomaterials 22 2001 2857 2865 (Pubitemid 32739242)
223. E. Turos, J.Y. Shim, Y. Wang, K. Greenhalgh, G.S. Reddy, S. Dickey, and D.V. Lim Antibiotic-conjugated polyacrylate nanoparticles: New opportunities for development of anti-MRSA agents Bioorg. Med. Chem. Lett. 17 1 2007 53 56 (Pubitemid 46001585)
224. S. Prior, C. Gamazo, J.M. Irache, H.P. Merkle, and B. Gander Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections Int. J. Pharm. 196 2000 115 125 (Pubitemid 30089520)
225. S. Svenson Dendrimers as versatile platform in drug delivery applications Eur. J. Pharm. Biopharm. 71 2009 445 462
226. H.K. Sajja, M.P. East, H. Mao, Y.A. Wang, S. Nie, and L. Yang Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect Curr. Drug Discov. Technol. 6 1 2009 43 51
227. E.R. Gillies, and J.M. Fréchet Dendrimers and dendritic polymers in drug delivery Drug Discov. Today 10 1 2005 35 43 (Pubitemid 40164817)
228. Y. Cheng, H. Qu, M. Ma, Z. Xu, P. Xu, Y. Fang, and T. Xu Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study Eur. J. Med. Chem. 42 2007 1032 1038 (Pubitemid 46907335)
229. C.Z. Chen, and S.L. Cooper Interactions between dendrimer biocides and bacterial membranes Biomaterials 23 16 2002 3359 3368 (Pubitemid 34615642)
230. M. Ma, Y. Cheng, Z. Xu, P. Xu, H. Qu, Y. Fang, T. Xu, and L. Wen Evaluation of Polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug Eur. J. Med. Chem. 42 2007 93 98 (Pubitemid 46198989)
231. D. Bhadra, S. Bhadra, and N.K. Jain Pegylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether J. Pharm. Pharmaceut. Sci. 8 3 2005 467 482 (Pubitemid 41529323)
232. S. Sandhiya, S.A. Dkhar, and A. Surendiran Emerging trends of nanomedicine-an overview Fundam. Clin. Pharmacol. 23 3 2009 263 269
233. M.H. Dufresne, D.L. Garrec, V. Sant, J.C. Leroux, and M. Ranger Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery Int. J. Pharm. 277 2004 81 90 (Pubitemid 38670423)
234. M.V. Risbud, A.A. Hardikar, S.V. Bhat, and R.R. Bhonde pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery J. Control. Release 68 1 2000 23 30 (Pubitemid 30407059)
235. Y.L. Hu, and J.Q. Gao Potential neurotoxicity of nanoparticles Int. J. Pharm. 394 1-2 2010 115 121
236. E.M. Hetrick, J.H. Shin, N.A. Stasko, C.B. Johnson, D.A. Wespe, E. Holmuhamedov, and M.H. Schoenfisch Bactericidal efficacy of nitric oxide-releasing silica nanoparticles ACS Nano 2 2 2008 235 246 (Pubitemid 351585938)
237. S.M. Moghimi, A.C. Hunter, and J.C. Murray Nanomedicine: current status and future prospects FASEB J. 19 3 2005 311 330 (Pubitemid 40316520)
238. B.G. Trewyn, C.M. Whitman, and V.S.Y. Lin Morphological control of room-temperature ionic liquid template mesoporous silica nanoparticles for controlled release of antibacterial agents Nano Lett. 4 11 2004 2139 2143
239. S.S. Suri, H. Fenniri, and B. Singh Nanotechnology-based drug delivery systems J. Occup. Med. Toxicol. 2 2007 16
240. A. El-Ansary, and S. Al-Daihan On the toxicity of therapeutically used nanoparticles: an overview J. Toxicol. 2009 754810
241. W.I. Hagens, A.G. Oomen, W.H. de Jong, F.R. Cassee, and A.J. Sips What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul. Toxicol. Pharmacol. 49 3 2007 217 229 (Pubitemid 350087396)
242. A. Poma, and M.L. Di Giorgio Toxicogenomics to improve comprehension of the mechanisms underlying responses of in vitro and in vivo systems to nanomaterials: a review Curr. Genomics 9 2008 571 585
243. W.H. De Jong, and P.J. Borm Drug delivery and nanoparticles: applications and hazards Int. J. Nanomedicine 3 2 2008 133 149 (Pubitemid 352042401)
244. R. Lei, C. Wu, B. Yang, H. Ma, C. Shi, Q. Wang, Q. Wang, Y. Yuan, and M. Liao Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity Toxicol. Appl. Pharmacol. 232 2 2008 292 301
245. D.C. Chalupa, P.E. Morrow, G. Oberdörster, M.J. Utell, and M.W. Frampton Ultrafine particle deposition in subjects with asthma Environ. Health Perspect. 112 8 2004 879 882 (Pubitemid 38811931)
246. S. Yoshida, K. Hiyoshi, S. Oshio, H. Takano, and T. Ichinose Effects of fetal exposure to carbon nanoparticles on reproductive function in male offspring Fertil. Steril. 93 5 2010 1695 1699
247. T. Komatsu, M. Tabata, M. Kubo-Irie, T. Shimizu, K. Suzuki, Y. Nihei, and K. Takeda The effects of nanoparticles on mouse testis Leydig cells in vitro Toxicol. In Vitro 22 8 2008 1825 1831
248. A. Kroll, M.H. Pillukat, D. Hahn, and J. Schnekenburger Current in vitro methods in nanoparticle risk assessment: limitations and challenges Eur. J. Pharm. Biopharm. 72 2009 370 377
249. A.M. Fayaz, K. Balaji, M. Girilal, R. Yadav, P.T. Kalaichelvan, and R. Venketesan Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria Nanomedine 6 2010 103 109
250. A. De Souza, D. Mehta, and R.W. Leavitt Bactericidal activity of combinations of silver-water dispersion with 19 antibiotics against seven microbial strains Curr. Sci. 91 2006 926 929 (Pubitemid 44654610)
251. R.T. Tom, V. Suryanarayanan, P.G. Reddy, S. Baskaran, and T. Pradeep Ciprofloxacin-protected gold nanoparticles Langmuir 20 5 2004 1909 1914
252. J. Lellouche, E. Kahana, S. Elias, A. Gedanken, and E. Banin Antibiofilm activity of nanosized magnesium fluoride Biomaterials 30 2009 5969 5978
253. N.M. Sanderson, and M.N. Jones Encapsulation of vancomycin and gentamicin within cationic liposomes for inhibition of growth of Staphylococcus epidermidis J. Drug Target. 4 3 1996 181 189 (Pubitemid 26390300)
254. P.C. Teixeira, G.M. Leite, R.J. Domingues, J. Silva, P.A. Gibbs, and J.P. Ferreira Antimicrobial effects of a microemulsion and a nanoemulsion on enteric and other pathogens and biofilms Int. J. Food Microbiol. 118 1 2007 15 19 (Pubitemid 47176150)
255. D.M. Livermore Of Pseudomonas, porins, pumps and carbapenems J. Antimicrob. Chemother. 47 2001 247 250 (Pubitemid 32229565)
256. D. Pérez-Conesa, L. McLandsborough, and J. Weiss Inhibition and inactivation of Listeria monocytogenes and Escherichia coli O157:H7 colony biofilms by micellar-encapsulated eugenol and carvacrol J. Food Prot. 69 12 2006 2947 2954 (Pubitemid 44954410)
257. S. Chono, T. Tanino, T. Seki, and K. Morimoto Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections J. Control. Release 127 2008 50 58
258. J.S. Patton, C.S. Fishburn, and J.G. Weers The lungs as a portal of entry for systemic drug delivery Proc. Am. Thorac. Soc. 1 4 2004 338 344
259. X. He, H. Zhang, Y. Ma, W. Bai, Z. Zhang, K. Lu, Y. Ding, Y. Zhao, and Z. Chai Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation Nanotechnology 21 28 2010 285103
260. J.M. Irache, H.H. Salman, C. Gamazo, and S. Espuelas Mannose-targeted systems for the delivery of therapeutics Expert Opin. Drug Deliv. 5 6 2008 703 724 (Pubitemid 351998259)
261. W. Wijagkanalan, S. Kawakami, M. Takenaga, R. Igarashi, F. Yamashita, and M. Hashida Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats J. Control. Release 125 2 2008 121 130 (Pubitemid 350299608)
262. D.L. Poelma, L.J. Zimmermann, H.H. Scholten, B. Lachmann, and J.F. Van Iwaarden In vivo and in vitro uptake of surfactant lipids by alveolar type II cells and macrophages Am. J. Physiol. Lung Cell. Mol. Physiol. 283 2002 L648 L654
263. M.M. Bailey, and C.J. Berkland Nanoparticle formulations in pulmonary drug delivery Med. Res. Rev. 29 1 2009 196 212
264. I. Roy, and N. Vij Nanodelivery in airway diseases: challenges and therapeutic applications Nanomedicine 6 2010 237 244
265. A. Misra, K. Jinturkat, D. Patel, J. Lalani, and M. Chougule Recent advances in liposomal dry powder formulations: preparation and evaluation Expert Opin. Drug Deliv. 6 1 2009 71 89
266. G.A. Peyman, H.C. Charles, K.R. Liu, B. Khoobehi, and M. Niesman Intravitreal liposome-encapsulated drugs: a preliminary human report Int. Ophthalmol. 12 3 1988 175 182 (Pubitemid 19008936)
267. C.I. Price, J.W. Horton, and C.R. Baxter Topical liposomal delivery of antibiotics in soft tissue infection J. Surg. Res. 49 2 1990 174 178 (Pubitemid 20241649)
268. K. Kanellakopoulou, and E.J. Giamarellos-Bourboulis Carrier systems for the local delivery of antibiotics in bone infections Drugs 59 6 2000 1223 1232 (Pubitemid 30410141)
269. K. Kanellakopoulou, N. Galanakis, E.J. Giamarellos-Bourboulis, C. Rifiotis, K. Papakostas, A. Andreopoulos, E. Dounis, P. Karagianakos, and H. Giamarellou Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin J. Antimicrob. Chemother. 46 2 2000 311 314 (Pubitemid 30639306)
270. J.K. Koort, E. Suokas, M. Veiranto, T.J. Mäkinen, J. Jalava, P. Törmälä, and H.T. Aro In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment J. Biomed. Mater. Res. A 1:78 3 2006 532 540 (Pubitemid 44253537)
271. P.K. Naraharisetti, H.C. Guan Lee, Y.C. Fu, D.J. Lee, and C.H. Wang In vitro and in vivo release of gentamicin from biodegradable discs J. Biomed. Mater. Res. B Appl. Biomater. 77 2 2006 329 337 (Pubitemid 43667456)
272. L.C. Li, J. Deng, and D. Stephens Polyanhydride implant for antibiotic delivery-from the bench to the clinic Adv. Drug Deliv. Rev. 54 2002 963 986
273. D. Neut, O.S. Kluin, B.J. Crielaard, H.C. van der Mei, H.J. Busscher, and D.W. Grijpma A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis Acta Orthop. 80 5 2009 514 519
274. W.T. Jia, X. Zhang, S.H. Luo, X. Liu, W.H. Huang, M.N. Rahaman, D.E. Day, D.Q. Zhang, Z.P. Xie, and J.Q. Wang Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis Acta Biomater. 6 2010 812 819
275. K. Nagahama, M. Hashizume, H. Yamamoto, T. Ouchi, and Y. Ohya Hydrophobically modified biodegradable poly(ethylene glycol) copolymers that form temperature-responsive nanogels Langmuir 25 17 2009 9734 9740
276. M. Qiao, D. Chen, X. Ma, and Y. Liu Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels Int. J. Pharm. 294 2005 103 112 (Pubitemid 40462325)
277. K.T. Peng, C.F. Chen, I.M. Chu, Y.M. Li, W.H. Hsu, R.W. Hsu, and P.J. Chang Treatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticles Biomaterials 31 2010 5227 5236
278. R. Schiffelers, G. Storm, and I. Bakker-Woudenberg Liposome encapsulated aminoglycosides in pre-clinical and clinical studies J. Antimicrob. Chemother. 48 2001 333 344 (Pubitemid 32898802)
279. E.B. Souto, and R.H. Müller SLN and NLC for topical delivery of ketoconazole J. Microencapsul. 22 2005 501 510 (Pubitemid 43123888)
280. M.S. Espuelas, P. Legrand, P.M. Loiseau, C. Bories, G. Barratt, and J.M. Irache In vitro antileishmanial activity of amphotericin B loaded in poly(1-Caprolactone) nanospheres J. Drug Target. 10 8 2002 593 599 (Pubitemid 36124359)
281. V.E. Kagan, H. Bayir, and A.A. Shvedova Nanomedicine and nanotoxicology: two sides of the same coin Nanomedicine 1 4 2005 313 316 (Pubitemid 43963640)